Evidence map›Paper›PMID 36386717›Full record

ArticleFrontiers in microbiology2022

Genomic diversity of resistant and virulent factors of

Muhammad Shafiq, Bixia Ke, Xin Li, Mi Zeng, Yumeng Yuan, Dongmei He, Xiaoling Deng, Xiaoyang Jiao

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Genomic dataset of eighteenCurrent research in microbial sciences · 2025
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Muhammad ShafiqDepartment of Cell Biology and Genetics, Shantou University Medical College, Shantou, China.
Bixia KeCenter for Disease Control and Prevention of Guangdong Province, Chinese Academy of Sciences, Guangzhou, China.
Xin LiDepartment of Cell Biology and Genetics, Shantou University Medical College, Shantou, China.
Mi ZengDepartment of Cell Biology and Genetics, Shantou University Medical College, Shantou, China.
Yumeng YuanDepartment of Cell Biology and Genetics, Shantou University Medical College, Shantou, China.
Dongmei HeCenter for Disease Control and Prevention of Guangdong Province, Chinese Academy of Sciences, Guangzhou, China.
Xiaoling DengCenter for Disease Control and Prevention of Guangdong Province, Chinese Academy of Sciences, Guangzhou, China.
Xiaoyang JiaoDepartment of Cell Biology and Genetics, Shantou University Medical College, Shantou, China.
Shantou University · CNGuangzhou Center for Disease Control and Prevention · CNChinese Academy of Sciences · CNShantou University Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Objectives: This study aims to determine the molecular epidemiology, resistant determinants, and genomic diversity of the clinical isolates of Methods: In this study, we obtained eight clinical Results: All isolates were susceptible to antibiotics commonly used for melioidosis treatment. Class D beta-lactamases genes OXA-57 and OXA-59, as well as various mutation factors such as Conclusion: The present study reports the identification of different mutation and virulence factors among

Indexed as

Burkholderia pseudomalleigenomic diversitymelioidosisresistancevirulence

Identifiers

PMID36386717
PMCPMC9649843
OpenAlexW4307706819

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.